Abstract:AIM: Transforming growth factor(TGF)beta(1) is involved in a variety of important cellular functions, including cell growth and differentiation, angiogenesis, immune function and extracellular matrix formation. However, the role of TGF beta(1) as an angiogenic factor in colorectal cancer is still unclear. We investigate the relationship between transforming growth factor beta(1) and angiogenesis by analyzing the expression of transforming growth factor(TGF) beta(1) in colorectal cancer, as well as its association with VEGF and MVD.METHODS: The expression of TGF beta(1),VEGF, as well as MVD were detected in 98 colorectal cancer by immunohistochemical staining. The relationship between the TGF beta(1) expression and VEGF expression, MVD was evaluated. To evaluate the effect of TGF beta(1) on the angiogenesis of colorectal cancers.RESULTS: Among 98 cases of colorectal cancer, 37 were positive for TGF beta(1) (37.8 %), 36 for VEGF (36.7 %), respectively. The microvessel counts ranged from 19 to 139. 8, with a mean of 48.7 ( standard deviation, 21.8). The expression of TGF beta(1) was correlated significantly with the depth of invasion, stage of disease, lymph node metastasis, VEGF expression and MVD. Patients in T3-T4, stage III-IV and with lymph node metastasis had much higher expression of TGF beta(1) than patients in T1-T2, stage I-II and without lymph node metastasis ( P < 0.05). The positive expression rate of VEGF (58.3 %) in the TGF-beta(1) positive group is higher than that in the TGF-beta(1) negative group(41.7 %, P < 0.05). Also, the microvessel count (54 +/- 18) in TGF-beta(1) positive group is significantly higher than that in TGF-beta(1) negative group (46 +/- 15, P < 0.05). The microvessel count in tumors with both TGF-beta(1) and VEGF positive were the highest (58 +/- 20, 36-140, P < 0.05). Whereas that in tumors with both TGF-beta(1) and VEGF negative were the lowest (38 +/- 16, 19-60, P < 0.05).CONCLUSION: TGF beta(1) might be associated with tumor progression by madulating the angiogenesis in colorectal cancer and TGF beta(1) may be used as a possible biomarker.

Effect of TGF-beta 1 on apoptosis of colon cancer cells via the ERK signaling pathway

Effect of TGF-β1 on Apoptosis of Colon Cancer Cells Via the ERK Signaling Pathway.

Transforming Growth Factor-Β1 Induces Glutathione Peroxidase-1 and Protects from H2O2-induced Cell Death in Colon Cancer Cells Via the Smad2/ERK1/2/HIF-1α Pathway.

TGFβ1I1 Suppressed Cell Migration and Invasion in Colorectal Cancer by Inhibiting the TGF-β Pathway and EMT Progress.

Pro-apoptotic and migration-suppressing potential of EGCG, and the involvement of AMPK in the p53-mediated modulation of VEGF and MMP-9 expression

Effect of Transforming Growth Factor-β1 on the Proliferation and Invasion of Human Colon Carcinoma Cells

Bevacizumab and anexelekto inhibitor, TP-0903 inhibits TGF-β1-induced epithelial-mesenchymal transition of colon cancer cells

TGF-β1 Mediates the Effects of Aspirin on Colonic Tumor Cell Proliferation and Apoptosis.

Tgf Beta(1) Expression and Angiogenesis in Colorectal Cancer Tissue

Ctgf Enhances Resistance to 5-Fu-mediating Cell Apoptosis Through Fak/Mek/Erk Signal Pathway in Colorectal Cancer

Celecoxib Induces Cell Apoptosis Coupled with Up-Regulation of the Expression of Vegf by A Mechanism Involving Er Stress in Human Colorectal Cancer Cells

Effect of celecoxib on expressions of MIF, PTEN and Caspase-3 in human colon cancer cell line HT-29

Effects of ERβ gene over-expression on proliferation and apoptosis of colonic cancer cells

Celecoxib induces apoptosis but up-regulates VEGF via endoplasmic reticulum stress in human colorectal cancer in vitro and in vivo

[Effects of Extracellular Signal-Regulated Kinase/mitogen-Activated Protein Kinase Signaling Pathway Activation on Proliferation and Cell Cycle Associated Genes in Human Colon Cancer Cells].

Transforming growth factor-β1 regulated phosphorylated AKT and interferon gamma expressions are associated with epithelial cell survival in rhesus macaque colon explants

Transforming Growth Factor Β Mediates Drug Resistance by Regulating the Expression of Pyruvate Dehydrogenase Kinase 4 in Colorectal Cancer

Transactivation of Egf Receptor and Erbb2 Protects Intestinal Epithelial Cells from Tnf-Induced Apoptosis

Effect of TGF-β_1 on cell growth inhibition in gastric carcinoma and drug-resistant gastric carcinoma cell lines and relationship with P53 and cyclin D1 protein expression

Anti-proliferation effect and its mechanism of TGF-β1 on gastric carcinoma and drug-resistant gastric carcinoma cells

Anti-TGF-β attenuates tumor growth via polarization of tumor associated neutrophils towards an anti-tumor phenotype in colorectal cancer